CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 7, 2004--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JP Morgan on Tuesday, January 13, 2004 at 11:00am EST (8:00am PST). Richard Pops, CEO of Alkermes, will provide an overview of the company and review corporate goals for 2004. The presentation will be webcast from the Westin St. Francis Hotel in San Francisco, California and may be accessed under the investor relation's tab at www.alkermes.com. The presentation will be archived for 30 days.
Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease(R) and Medisorb(R) delivery systems and the development of inhaled pharmaceutical products based on our proprietary Advanced Inhalation Research, Inc., ("AIR(R)") pulmonary delivery system. Our business strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Massachusetts headquarters, research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.
CONTACT: Alkermes, Inc.
Rebecca Peterson, 617-583-6378
Director, Corporate Communications
SOURCE: Alkermes, Inc.